Skip to content

Evaluation accuracy of captopril challenge test and saline infusion test for primary aldosteronism diagnostic: 16 cases and literature review

Evaluation accuracy of captopril challenge test and saline infusion test for primary aldosteronism diagnostic: 16 cases and literature review

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108642
Enrollment
Unknown
Registered
2025-09-02
Start date
2025-09-03
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary aldosteronism

Interventions

Gold Standard:Aldosterone-to-ReninRatio, ARR
Index test:Captopril Challenge Test, CCT
Saline Infusion Test, SIT

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
27 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Hypertensive patients who tested positive for ARR screening or patients who tested negative for ARR screening but were ultimately diagnosed with PA; 2.Patients who have undergone SIT and/or CCT confirmation trials; 3.Complete clinical data, including biochemical tests, imaging examinations, and final diagnostic results;

Exclusion criteria

Exclusion criteria: 1.Patients with negative ARR screening and no other PA diagnostic basis; 2.Patients with incomplete clinical data or inability to make accurate diagnosis; 3.Patients with combined endocrine disorders or severe cardiovascular diseases;

Design outcomes

Primary

MeasureTime frame
CCT;SIT;Aldosterone-to-ReninRatio, ARR;Accuracy;Sensitivity;Specificity;

Countries

China

Contacts

Public ContactZiguang Niu

Shanghai General Hospital

niuzguang@163.com+86 189 1693 2143

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026